About this Journal Submit a Manuscript Table of Contents
Journal of Nutrition and Metabolism
Volume 2012 (2012), Article ID 381713, 10 pages
Review Article

Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective

Department of Diabetes, University Hospital Llandough, Cardiff CF64 2XX, UK

Received 7 August 2012; Accepted 21 September 2012

Academic Editor: Maurizio Muscaritoli

Copyright © 2012 Dominique Xavier Brown and Marc Evans. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • K. J. Neff, A. H. Frankel, F. W. K. Tam, D. M. Sadlier, C. Godson, and C. W. le Roux, “The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation,” Nephrology Dialysis Transplantation, 2013. View at Publisher · View at Google Scholar
  • Manfredi Rizzo, Dragana Nikolic, Maciej Banach, Rosaria Vincenza Giglio, Angelo Maria Patti, Vittoria Di Bartolo, Annamaria Tamburello, Aantonella Zabbara, Giuseppina Pecoraro, Giuseppe Montalto, and Ali A. Rizvi, “The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspective,” Clinical Lipidology, vol. 8, no. 2, pp. 173–181, 2013. View at Publisher · View at Google Scholar
  • Annalisa Capuano, Francesco Rossi, Liberata Sportiello, Maria Ida Maiorino, Dario Giugliano, and Katherine Esposito, “Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy - focus on alogliptin,” Drug Design Development And Therapy, vol. 7, pp. 989–1001, 2013. View at Publisher · View at Google Scholar
  • Michelle Orme, Peter Fenici, Isabelle Duprat Lomon, Gail Wygant, Rebecca Townsend, and Marina Roudaut, “A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy,” Diabetology & Metabolic Syndrome, vol. 6, 2014. View at Publisher · View at Google Scholar
  • K Pabreja, M A Mohd, C Koole, D Wootten, and S G B Furness, “Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation,” British Journal of Pharmacology, vol. 171, no. 5, pp. 1114–1128, 2014. View at Publisher · View at Google Scholar
  • Robert B Jones, Steven P Vickers, Sharon C Cheetham, Katie R Headland, Michael Mark, and Thomas Klein, “Effect Of Linagliptin, Alone And In Combination With Voglibose Or Exendin-4, On Glucose Control In Male Zdf Rats,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • André J Scheen, “A review of gliptins for 2014,” Expert Opinion on Pharmacotherapy, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Bhumika D. Patel, and Manjunath D. Ghate, “Recent Approaches to Medicinal Chemistry and Therapeutic Potential of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors,” European Journal of Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Karoline von Websky, Christoph Reichetzeder, and Berthold Hocher, “Physiology and pathophysiology of incretins in the kidney,” Current Opinion in Nephrology and Hypertension, vol. 23, no. 1, pp. 54–60, 2014. View at Publisher · View at Google Scholar
  • Johannes Werzowa, Marcus Säemann, Michael Haidinger, Michael Krebs, and Manfred Hecking, “Antidiabetic Therapy in Post Kidney Transplantation Diabetes Mellitus,” Transplantation Reviews, 2015. View at Publisher · View at Google Scholar